NCT01351129View on ClinicalTrials.gov

Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Healthy
Interventions
DRUG

Formulation 1

150-mg immediate release tablet (single dose)

DRUG

Formulation 2

150-mg modified release capsule, short duration (single dose)

DRUG

Formulation 3

150-mg modified release capsule, long duration (single dose)

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01351129 - Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers | Biotech Hunter | Biotech Hunter